Catalyst Wire Dossier Catalyst Wire Dossier

sIPV (Sabin-based trivalent inactivated poliovirus vaccine)

Sabin-based trivalent inactivated poliovirus vaccine · Janssen Vaccines & Prevention B.V.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for sIPV (Sabin-based trivalent inactivated poliovirus vaccine), covering 2025-02-03 to 2025-02-03. Get the full timeline:

Most recent: Clinical Trial Update: A First in Human Study to Assess the Safety, Tolerability and Immunogenicity of a Single Dose of a Trivalent Inactivated Poliovirus Vaccine Based on Sabin Strains (sIPV) Given Intramuscularly in Healthy Adults [Phase 1]

See pricing